Home RxNorm 1357888 methylprednisolone 2000 MG Injection [Solu-Medrol] Drug identity information. FDA.report links public drug records from RxNav, DailyMed, FDA NDC, Drugs@FDA, and related public sources where available. This page is informational only and is not medical, prescribing, or regulatory advice.
RxCUI 1357888
RxNorm name methylprednisolone 2000 MG Injection [Solu-Medrol]
Display name SOLU-Medrol (Injectable)
Full name methylprednisolone 2000 MG Injection [Solu-Medrol]
Term type SBD
Status Active
Strength 2,000 mg
Dose form Injection
Route Injectable
Updated 2026-10-24 12:26:41 RxNorm Status History#
Status Active
Source RXNORM
Current YES
Release start 122012
Active start 122012
Multiple ingredient NO
Branded YES Ingredients And Strength# Derived Ingredient Concepts# FDA NDC Products And Packages# Package NDC, Product NDC, Name table Package NDC Product NDC Name Labeler Application 0009-0850-01 0009-0850 SOLU-MEDROL methylprednisolone sodium succinate Pharmacia & Upjohn Company LLC NDA011856
Drugs@FDA Applications# Application, NDC, Name table Application NDC Name Marketing category Labeler NDA011856 0009-0850 SOLU-MEDROL methylprednisolone sodium succinate NDA Pharmacia & Upjohn Company LLC
RxNav Current And Historical NDCs# RxNav current and historical NDC rows page 1 of 1 · 2 matching rows.
NDC11, Source, Active table NDC11 Source Active 00009085001 rxnav_ndcs yes 00009079601 rxnav_historical
UNII Substances# UNII substance links page 1 of 1 · 0 matching rows.
No records found.
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed RxNorm Mappings# unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.
Set ID, RxNorm mappings, Terms table Set ID RxNorm mappings Terms SPL version Label Effective cd99be87-c8d9-48d6-a8e5-e081052e3f19 SOLU-Medrol 2 GM Injection [PSN] · methylprednisolone 2000 MG Injection [Solu-Medrol] [SBD] · Solu-Medrol (as methylprednisolone sodium succinate) 2 GM Injection [SY] · Solu-Medrol 2000 MG Injection [SY] 4 35 SOLU-MEDROL ® (methylprednisolone sodium succinate for injection, USP) 20251202
Recently Linked DailyMed Labels# Drug Classes# Source, Class ID, Class table Source Class ID Class Type Relationship Drug concept ATC D10AA Corticosteroids, combinations for treatment of acne ATC1-4 methylprednisolone ATC D07AA Corticosteroids, weak (group I) ATC1-4 methylprednisolone ATC H02AB Glucocorticoids ATC1-4 methylprednisolone FDASPL N0000175576 Corticosteroid EPC has_epc methylprednisolone FDASPL N0000175450 Corticosteroid Hormone Receptor Agonists MOA has_moa methylprednisolone MEDRT D008775 Methylprednisolone CHEM has_ingredient methylprednisolone MEDRT D000309 Adrenal Insufficiency DISEASE may_treat methylprednisolone MEDRT D015210 Arthritis, Gouty DISEASE may_prevent methylprednisolone MEDRT D001172 Arthritis, Rheumatoid DISEASE may_prevent methylprednisolone MEDRT D001249 Asthma DISEASE may_treat methylprednisolone MEDRT D001607 Berylliosis DISEASE may_treat methylprednisolone MEDRT D001932 Brain Neoplasms DISEASE may_treat methylprednisolone MEDRT D003093 Colitis, Ulcerative DISEASE may_treat methylprednisolone MEDRT D003874 Dermatitis Herpetiformis DISEASE may_treat methylprednisolone MEDRT D003876 Dermatitis, Atopic DISEASE may_treat methylprednisolone MEDRT D004342 Drug Hypersensitivity DISEASE ci_with methylprednisolone MEDRT D004892 Erythema Multiforme DISEASE may_treat methylprednisolone MEDRT D006086 Graft vs Host Disease DISEASE may_prevent methylprednisolone MEDRT D006086 Graft vs Host Disease DISEASE may_treat methylprednisolone MEDRT D006402 Hematologic Diseases DISEASE may_treat methylprednisolone MEDRT D006934 Hypercalcemia DISEASE may_treat methylprednisolone MEDRT D007223 Infant DISEASE ci_with methylprednisolone MEDRT D007249 Inflammation DISEASE may_treat methylprednisolone MEDRT D007938 Leukemia DISEASE may_treat methylprednisolone MEDRT D008180 Lupus Erythematosus, Systemic DISEASE may_treat methylprednisolone MEDRT D009103 Multiple Sclerosis DISEASE may_treat methylprednisolone MEDRT D009181 Mycoses DISEASE ci_with methylprednisolone MEDRT D009182 Mycosis Fungoides DISEASE may_treat methylprednisolone MEDRT D009404 Nephrotic Syndrome DISEASE may_treat methylprednisolone MEDRT D009461 Neurologic Manifestations DISEASE may_treat methylprednisolone MEDRT D010392 Pemphigus DISEASE may_treat methylprednisolone MEDRT D012128 Respiratory Distress Syndrome DISEASE may_treat methylprednisolone MEDRT D012216 Rheumatic Diseases DISEASE may_treat methylprednisolone MEDRT D012507 Sarcoidosis DISEASE may_treat methylprednisolone MEDRT D012713 Serum Sickness DISEASE may_treat methylprednisolone MEDRT D012874 Skin Diseases, Infectious DISEASE ci_with methylprednisolone MEDRT D013167 Spondylitis, Ankylosing DISEASE may_treat methylprednisolone MEDRT D013585 Synovitis DISEASE may_treat methylprednisolone MEDRT D013966 Thyroiditis DISEASE may_treat methylprednisolone MEDRT D014397 Tuberculosis, Pulmonary DISEASE may_treat methylprednisolone MEDRT D014605 Uveitis DISEASE may_treat methylprednisolone MEDRT N0000000159 Glucocorticoid Receptor Agonists MOA has_moa methylprednisolone MEDRT N0000000134 Lipoxygenase Inhibitors MOA has_moa methylprednisolone MEDRT N0000008327 Carbohydrate Metabolism Alteration PE has_pe methylprednisolone MEDRT N0000010253 Decreased Capillary Permeability PE has_pe methylprednisolone MEDRT N0000010248 Decreased Fibroblast Migration PE has_pe methylprednisolone MEDRT N0000008645 Decreased Glucocorticoid Secretion PE has_pe methylprednisolone MEDRT N0000008681 Decreased Leukotriene Activity PE has_pe methylprednisolone MEDRT N0000010246 Decreased Polymorphonuclear Leukocyte Migration PE has_pe methylprednisolone MEDRT N0000008834 Decreased Prostaglandin Activity PE has_pe methylprednisolone MEDRT N0000008841 Decreased Protein Synthesis PE has_pe methylprednisolone MEDRT N0000009004 Decreased Thromboxane Activity PE has_pe methylprednisolone MEDRT N0000009739 Lipid Metabolism Alteration PE has_pe methylprednisolone MEDRT N0000009741 Lysosomal Function Alteration PE has_pe methylprednisolone
Properties# Category, Property, Value table Category Property Value ATTRIBUTES AVAILABLE_STRENGTH 2000 MG ATTRIBUTES GENERAL_CARDINALITY SINGLE ATTRIBUTES HUMAN_DRUG US ATTRIBUTES RXNAV_HUMAN_DRUG US ATTRIBUTES SCHEDULE 0 CODES NDA NDA011856 NAMES Prescribable Synonym SOLU-Medrol 2 GM Injection NAMES Tallman Synonym methylPREDNISolone 2000 MG Injection [SOLU-Medrol] NAMES Tallman Synonym SOLU-Medrol (as methylPREDNISolone sodium succinate) 2 GM Injection NAMES Tallman Synonym SOLU-Medrol 2000 MG Injection SOURCES Source Gold Standard Alchemy SOURCES Source Metathesaurus FDA Structured Product Labels SOURCES Source Micromedex RED BOOK SOURCES Source Multum MediSource Lexicon